title: NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance.
authors.forename: P
authors.initials: P
authors.lastname: Ballerini
authors.forename: M
authors.initials: M
authors.lastname: Busson
authors.forename: S
authors.initials: S
authors.lastname: Fasola
authors.forename: J
authors.initials: J
authors.lastname: van den Akker
authors.forename: H
authors.initials: H
authors.lastname: Lapillonne
authors.forename: S P
authors.initials: SP
authors.lastname: Romana
authors.forename: P
authors.initials: P
authors.lastname: Marynen
authors.forename: O A
authors.initials: OA
authors.lastname: Bernard
authors.forename: J
authors.initials: J
authors.lastname: Landman-Parker
authors.forename: R
authors.initials: R
authors.lastname: Berger
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D002883:Chromosomes, Human, Pair 14 / Q000235:genetics*; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics*; D020732:Cytogenetic Analysis; D015973:Gene Expression Regulation, Leukemic; D016313:Genes, abl / Q000235:genetics*; D018398:Homeodomain Proteins / Q000235:genetics*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D028861:Nuclear Pore Complex Proteins / Q000235:genetics*; D015513:Oncogene Proteins / Q000235:genetics*; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics*; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents; D018398:Homeodomain Proteins; C085914:NUP214 protein, human; D028861:Nuclear Pore Complex Proteins; D015513:Oncogene Proteins; D015514:Oncogene Proteins, Fusion; C489494:TLX3 protein, human